GlaxoSmithKline: Dermatitis trials

The registry lists 11 Dermatitis studies with GlaxoSmithKline as lead sponsor. 0 are open to participants now and 5 have results posted.

Phase 1 4Phase 2 2Phase 3 2Phase 4 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Long-Term Study (AtDvance) to Evaluate GSK1070806 in Atopic Dermatitis.TerminatedNCT06447506Phase 2Results posted
• A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic DermatitisTerminatedNCT05999799Phase 2Results posted
• Ethanol-Free Clobetasol Propionate Foam 0.05% (Olux-E Foam) vs Vehicle Foam in the Treatment of Chronic Hand Dermatitis.CompletedNCT01323673Phase 4Results posted
• Study to Evaluate Safety, Efficacy and Tolerability of Clobetasol Propionate for Chronic Hand DermatitisCompletedNCT00828464Phase 4Results posted
• STUDY TO ASSESS THE LONG-TERM SAFETY OF EXTINA (KETOCONAZOLE) FOAM, 2%CompletedNCT00703846Phase 4Results posted
• Phase 1 Study of LevocetirizineCompletedNCT02447393Phase 1
• Minocycline Bioequivalence StudyCompletedNCT01938508Phase 1
• Characterisation of T-cell Response to Keyhole Limpet Hemocyanin (KLH) and Tuberculin Purified Protein Derivative (PPD)CompletedNCT01910662Phase 1
• Randomised, Double-blind, Placebo-controlled Study of Topical Clobetasone Butyrate 0.05% Cream in Subjects With Eczema for Two Weeks to Evaluate the Efficacy and SafetyCompletedNCT01567995Phase 3
• Study on Anti-inflammatory Effects of Topical R115866 GelCompletedNCT00719121Phase 1
• Study Of Atopic Dermatitis In PediatricsCompletedNCT00257569Phase 3